BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 2423135)

  • 1. Superactivity of human phosphoribosyl pyrophosphate synthetase due to altered regulation by nucleotide inhibitors and inorganic phosphate.
    Becker MA; Losman MJ; Wilson J; Simmonds HA
    Biochim Biophys Acta; 1986 Jun; 882(2):168-76. PubMed ID: 2423135
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Variant human phosphoribosylpyrophosphate synthetase altered in regulatory and catalytic functions.
    Becker MA; Raivio KO; Bakay B; Adams WB; Nyhan WL
    J Clin Invest; 1980 Jan; 65(1):109-20. PubMed ID: 6243137
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neurodevelopmental impairment and deranged PRPP and purine nucleotide synthesis in inherited superactivity of PRPP synthetase.
    Becker MA; Puig JG; Mateos FA; Jimenez ML; Kim M; Simmonds HA
    Adv Exp Med Biol; 1989; 253A():15-22. PubMed ID: 2483028
    [No Abstract]   [Full Text] [Related]  

  • 4. Inherited superactivity of phosphoribosylpyrophosphate synthetase: association of uric acid overproduction and sensorineural deafness.
    Becker MA; Puig JG; Mateos FA; Jimenez ML; Kim M; Simmonds HA
    Am J Med; 1988 Sep; 85(3):383-90. PubMed ID: 2843048
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gout with superactive phosphoribosylpyrophosphate synthetase due to increased enzyme catalytic rate.
    Becker MA; Losman MJ; Itkin P; Simkin PA
    J Lab Clin Med; 1982 Apr; 99(4):495-511. PubMed ID: 6174658
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Superactivity of phosphoribosylpyrophosphate synthetase, due to feedback resistance, causing purine overproduction and gout.
    Sperling O; Boer P; Brosh S; Zoref E; de Vries A
    Ciba Found Symp; 1977; (48):143-64. PubMed ID: 204460
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutant feedback-resistant phosphoribosylpyrophosphate synthetase associated with purine overproduction and gout. Phosphoribosylpyrophosphate and purine metabolism in cultured fibroblasts.
    Zoref E; De Vries A; Sperling O
    J Clin Invest; 1975 Nov; 56(5):1093-9. PubMed ID: 171280
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [PRPP synthetase superactivity].
    Fujimori S
    Nihon Rinsho; 1996 Dec; 54(12):3309-14. PubMed ID: 8976111
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inherited phosphoribosylpyrophosphate synthetase superactivity due to aberrant inhibitor and activator responsiveness.
    Becker MA; Losman MJ; Simmonds HA
    Adv Exp Med Biol; 1986; 195 Pt A():59-66. PubMed ID: 3014841
    [No Abstract]   [Full Text] [Related]  

  • 10. PRPP and purine nucleotide metabolism in human lymphoblasts with both PRPP synthetase superactivity and HGPRT deficiency.
    Becker MA; Kim M; Husain K
    Adv Exp Med Biol; 1989; 253B():13-20. PubMed ID: 2481968
    [No Abstract]   [Full Text] [Related]  

  • 11. Patterns of phosphoribosylpyrophosphate and ribose-5-phosphate concentration and generation in fibroblasts from patients with gout and purine overproduction.
    Becker MA
    J Clin Invest; 1976 Feb; 57(2):308-18. PubMed ID: 176178
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Superactive phosphoribosylpyrophosphate synthetase with altered regulatory and catalytic properties.
    Becker MA; Raivio KO; Bakay B; Adams WB; Nyhan WL
    Adv Exp Med Biol; 1980; 122A():387-92. PubMed ID: 6158850
    [No Abstract]   [Full Text] [Related]  

  • 13. Phosphoribosylpyrophosphate synthetase superactivity. A study of five patients with catalytic defects in the enzyme.
    Becker MA; Losman MJ; Rosenberg AL; Mehlman I; Levinson DJ; Holmes EW
    Arthritis Rheum; 1986 Jul; 29(7):880-8. PubMed ID: 3017368
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selective expression of phosphoribosylpyrophosphate synthetase superactivity in human lymphoblast lines.
    Losman MJ; Rimon D; Kim M; Becker MA
    J Clin Invest; 1985 Oct; 76(4):1657-64. PubMed ID: 2414323
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanisms of accelerated purine nucleotide synthesis in human fibroblasts with superactive phosphoribosylpyrophosphate synthetases.
    Becker MA; Losman MJ; Kim M
    J Biol Chem; 1987 Apr; 262(12):5596-602. PubMed ID: 3032938
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overproduction disease in man due to enzyme feedback resistance mutation. Purine overproduction in gout due to excessive activity of mutant feedback-resistant phosphoribosylpyrophosphate synthetase.
    Sperling O; Boer P; Brosh S; Zoref E; de Vries A
    Enzyme; 1978; 23(1):1-9. PubMed ID: 203449
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phosphoribosyl pyrophosphate and phosphoribosyl pyrophosphate synthetase in rat mammary gland. Changes in the lactation cycle and effects of diabetes, insulin and phenazine methosulphate.
    Kunjara S; Sochor M; Salih N; McLean P; Greenbaum AL
    Biochem J; 1986 Sep; 238(2):553-9. PubMed ID: 2432883
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of purine synthesis de novo in human fibroblasts by purine nucleotides and phosphoribosylpyrophosphate.
    Becker MA; Kim M
    J Biol Chem; 1987 Oct; 262(30):14531-7. PubMed ID: 2444588
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased purine nucleotide degradation in the central nervous system (CNS) in PRPP synthetase superactivity.
    Jiménez ML; Puig JG; Mateos FA; Ramos TH; Melián JS; Nieto VG; Becker MA
    Adv Exp Med Biol; 1989; 253A():9-13. PubMed ID: 2560341
    [No Abstract]   [Full Text] [Related]  

  • 20. PRPP synthetase superactivity in lymphoblast lines.
    Becker MA; Losman MJ; Rimon D; Kim M
    Adv Exp Med Biol; 1986; 195 Pt A():51-8. PubMed ID: 3014839
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.